I thought it might rally a bit more, but there’s just nobody really the company. Agree it we can continue to hold .30 or so that would be nice. Revenue growth hopefully continues to accelerate and favorite trial results occur. That’s a way out and would be the payoff.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.